Abstract
Drug delivery in the field of medicine is a system that was developed mainly for the purpose of releasing, localizing, and targeting drugs at a particular site in the body, at the right time, period, and dose. The use of natural biopolymers in drug delivery systems dates back to as far as 1970. This is due to the uniqueness of their properties, especially their ability to undergo biodegradation. The use of these biopolymers have contributed largely to the advancement of this technology by adding its own properties to the drugs. Biopolymers like polysaccharides, polyesters, and polyamides are few examples of natural biopolymers employed for this application. They are produced by microorganisms and the fact that the microorganisms can be genetically manipulated gives room for the production of a wide range of biopolymers. Their existence ranges from viscous solutions to even plastics. Also, their physical properties depend on the composition of the biopolymer as well as its molecular weight. The ability to produce natural biopolymers with personalized properties via biotechnological techniques opens them up to several medical applications such as drug delivery. The properties, structure, synthesis, and most importantly the application of some natural biopolymers in drug delivery will be discussed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ad EA, Sin A (2013) Handbook of biopolymers and biodegradable plastics. Elsevier/William Andrew
Aggarwal G, Dhawan S (2009) Development, fabrication and evaluation of transdermal drug delivery system—a review. Pharmainfo.net, 7
Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Controlled Release 100:5–28
Akanksha B, Ganesh K, Preeti K (2014) Indian J Novel Drug Delivery 6:215–222
Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–1822
Alves N, Mano J (2008) Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications. Int J Biol Macromol 43:401–414
Anderson AJ, Dawes EA (1990) Occurrence, metabolism, metabolic role, and industrial uses of bacterial polyhydroxyalkanoates. Microbiol Rev 54:450–472
Andrade F, Goycoolea F, Chiappetta DA, Das Neves J, Sosnik A, Sarmento B (2011) Chitosan-grafted copolymers and chitosan-ligand conjugates as matrices for pulmonary drug delivery. Int J Carbohyd Chem 2011
Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J (2007) Magnetic nanoparticles for drug delivery. Nano Today 2:22–32
Bae Y, Kataoka K (2006) Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugation. J Controlled Release 116:e49–e50
Banakar UV (1987) Drug delivery systems of the 90s: innovations in controlled release. Am Pharm 27:39–44
Bansal V, Sharma PK, Sharma N, Pal OP, Malviya R (2011) Applications of chitosan and chitosan derivatives in drug delivery. Adv Biol Res 5:28–37
Basarkar A, Singh J (2009) Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice. Pharm Res 26:72–81
Bender AR, Von Briesen H, Kreuter J, Duncan IB, Rübsamen-Waigmann H (1996) Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro. Antimicrob Agents Chemother 40:1467–1471
Berth G, Dautzenberg H, Peter MG (1998) Physico-chemical characterization of chitosans varying in degree of acetylation. Carbohyd Polym 36:205–216
Berthold A, Cremer K, Kreuter J (1998) Collagen microparticles: carriers for glucocorticosteroids. Eur J Pharm Biopharm 45:23–29
Bhattarai N, Gunn J, Zhang M (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 62:83–99
Bhattarai N, Ramay HR, Gunn J, Matsen FA, Zhang M (2005) PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J Controlled Release 103:609–624
Bhise KS, Dhumal RS, Paradkar AR, Kadam SS (2008) Effect of drying methods on swelling, erosion and drug release from chitosan–naproxen sodium complexes. AAPS PharmSciTech 9:1–12
Bhowmik D, Gopinath H, Kumar BP, Duraivel S, Kumar KS (2012) Controlled release drug delivery systems. Pharma Innov 1
Bhowmik D, Kumar KS, Bhanot R (2017) Recent advances in transdermal drug delivery system. LAP LAMBERT Academic Publishing
Bissery M, Valeriote F, Thies C (1985) Therapeutic efficacy of CCNU-loaded microspheres prepared from poly (D, L) lactide (PLA) or poly-B-hydroxybutyrate (PHB) against Lewis lung (LL) carcinoma. In: Proceedings of the American Association for Cancer Research. AMER ASSOC CANCER RESEARCH PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W., PHILADELPHIA, PA 19106, 355
Boopathy R (2000) Factors limiting bioremediation technologies. Biores Technol 74:63–67
Brahmankar D, Jaiswal S (2009) Biopharmaceutics and Pharmacokinetics: pharmacokinetics. Vallabh Prakashan, pp 399–401
Brigger I, Dubernet C, Couvreur P (2012) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 64:24–36
Brigham CJ, Sinskey AJ (2012) Applications of polyhydroxyalkanoates in the medical industry. International Journal of Biotechnology for Wellness Industries 1:52–60
Brugnerotto J, Desbrières J, Roberts G, Rinaudo M (2001) Characterization of chitosan by steric exclusion chromatography. Polymer 42:09921–09927
Byrom D (1987) Polymer synthesis by microorganisms: technology and economics. Trends Biotechnol 5:246–250
Cammas S, Bear M-M, Moine L, Escalup R, Ponchel G, Kataoka K, Guérin P (1999) Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the design of biocompatible hydrolyzable devices. Int J Biol Macromol 25:273–282
Cardoso MJ, Costa RR, Mano JF (2016) Marine origin polysaccharides in drug delivery systems. Marine drugs 14:34
Chandra R, Rustgi R (1998) Biodegradable polymers. Prog Polym Sci 23:1273–1335
Chang S, Kramer W, Feldman S, Ballentine R, Frankel L (1981) Bioavailability of allopurinol oral and rectal dosage forms. Am J Health-Syst Pharm 38:365–368
Chen H, Langer R (1998) Oral particulate delivery: status and future trends. Adv Drug Deliv Rev 34:339–350
Chen S, Li Y, Guo C, Wang J, Ma J, Liang X, Yang L-R, Liu H-Z (2007) Temperature-responsive magnetite/PEO–PPO–PEO block copolymer nanoparticles for controlled drug targeting delivery. Langmuir 23:12669–12676
Cölfen H, Berth G, Dautzenberg H (2001) Hydrodynamic studies on chitosans in aqueous solution. Carbohyd Polym 45:373–383
Connal LA, Li Q, Quinn JF, Tjipto E, Caruso F, Qiao GG (2008) pH-responsive poly (acrylic acid) core cross-linked star polymers: morphology transitions in solution and multilayer thin films. Macromolecules 41:2620–2626
Costa RR, Custódio CA, Arias FJ, Rodríguez-Cabello JC, Mano JF (2013) Nanostructured and thermoresponsive recombinant biopolymer-based microcapsules for the delivery of active molecules. Nanomed Nanotechnol Biol Med 9:895–902
Costa RR, Martín L, Mano JF, Rodríguez‐Cabello JC (2012) Elastin‐like macromolecules. In: Biomimetic approaches for biomaterials development, pp 93–116
Couto DS, Hong Z, Mano JF (2009) Development of bioactive and biodegradable chitosan-based injectable systems containing bioactive glass nanoparticles. Acta Biomater 5:115–123
Daamen WF, Veerkamp J, Van Hest J, Van Kuppevelt T (2007) Elastin as a biomaterial for tissue engineering. Biomaterials 28:4378–4398
De La Fuente M, Raviña M, Paolicelli P, Sanchez A, Seijo B, Alonso MJ (2010) Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 62:100–117
Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D (2006) Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12:1317–1324
Díaz A, Katsarava R, Puiggalí J (2014) Synthesis, properties and applications of biodegradable polymers derived from diols and dicarboxylic acids: From polyesters to poly (ester amide)s. Int J Mol Sci 15:7064–7123
Doillon CJ, Silver FH, Berg RA (1987) Fibroblast growth on a porous collagen sponge containing hyaluronic acid and fibronectin. Biomaterials 8:195–200
Donaldson K, Stone V, Tran C, Kreyling W, Borm PJ (2004) Nanotoxicology. BMJ Publishing Group Ltd
Doshi N, Mitragotri S (2009) Designer biomaterials for nanomedicine. Adv Func Mater 19:3843–3854
Efthimiadou EK, Metaxa A-F, Kordas G (2015) Modified polysaccharides for drug delivery. Polysaccharides: Bioactivity and Biotechnology, pp 1805–1835
El-Samaligy M, Rohdewald P (1983) Reconstituted collagen nanoparticles, a novel drug carrier delivery system. J Pharm Pharmacol 35:537–539
Elzoghby AO, El-Fotoh WSA, Elgindy NA (2011) Casein-based formulations as promising controlled release drug delivery systems. J Controlled Release 153:206–216
Elzoghby AO, Samy WM, Elgindy NA (2012) Albumin-based nanoparticles as potential controlled release drug delivery systems. J Controlled Release 157:168–182
Elzoghby AO, Samy WM, Elgindy NA (2012) Protein-based nanocarriers as promising drug and gene delivery systems. J Controlled Release 161:38–49
Errington N, Harding S, Vårum K, Illum L (1993) Hydrodynamic characterization of chitosans varying in degree of acetylation. Int J Biol Macromol 15:113–117
Fee M, Errington N, Jumel K, Illum L, Smith A, Harding SE (2003) Correlation of SEC/MALLS with ultracentrifuge and viscometric data for chitosans. Eur Biophys J 32:457–464
Felt O, Buri P, Gurny R (1998) Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 24:979–993
Friess W (1998) Collagen–biomaterial for drug delivery1. Eur J Pharm Biopharm 45:113–136
Fujioka K, Takada Y, Sato S, Miyata T (1995) Novel delivery system for proteins using collagen as a carrier material: the minipellet. J Controlled Release 33:307–315
Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ (2004) Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 54:1019–1024
Gandhi KJ, Deshmane SV, Biyani KR (2012) Polymers in pharmaceutical drug delivery system: a review. International journal of pharmaceutical sciences review and research 14:10
Gangrade N, Price JC (1991) Poly (hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties. J Microencapsul 8:185–202
Gates KA, Grad H, Birek P, Lee PI (1994) A new bioerodible polymer insert for the controlled release of metronidazole. Pharm Res 11:1605–1609
Gelse K, Pöschl E, Aigner T (2003) Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev 55:1531–1546
Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353:38–52
Gould PL, Holland SJ, Tighe BJ (1987) Polymers for biodegradable medical devices. IV. Hydroxybutyrate-valerate copolymers as non-disintegrating matrices for controlled-release oral dosage forms. Int J Pharm 38:231–237
Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603
Gupta M, Sharma V (2011) Targeted drug delivery system: a Review. ResJ Chem Sci 1:134–138
Gürsel İ, Korkusuz F, Türesin F, Alaeddinoǧlu NG, Hasrc V (2000) In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 22:73–80
Gursel I, Yagmurlu F, Korkusuz F, Hasirci V (2002) In vitro antibiotic release from poly (3-hydroxybutyrate-co-3-hydroxyvalerate) rods. J Microencapsul 19:153–164
Harding SE (2006) Trends in muco-adhesive analysis. Trends Food Sci Technol 17:255–262
Harding SE, Davis SB, Deacon MP, Fiebrig I (1999) Biopolymer mucoadhesives. Biotechnol Genet Eng Rev 16:41–86
Hardy JG, Davis SS, Wilson CG (1989) Drug delivery to the gastrointestinal tract. Ellis Horwood, UK
Heiati H, Phillips NC, Tawashi R (1996) Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride. Pharm Res 13:1406–1410
Holmes P (1988) Biologically produced (R)-3-hydroxy-alkanoate polymers and copolymers. In: Developments in crystalline polymers. Springer
Ilium L (1998) Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326–1331
Illum L (2002) Nasal drug delivery: new developments and strategies. Drug Discovery Today 7:1184–1189
Jain D, Panda AK, Majumdar DK (2005) Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech 6:E100–E107
Jain KK (2008) Nanomedicine: application of nanobiotechnology in medical practice. Med Principles Pract 17:89–101
Jalwal P, Jangra A, Dahiya L, Sangwan Y, Saroha R (2010) A review on transdermal patches. Pharma Res 3:139–149
Jantzen GM, Robinson JR (1996) Sustained-and controlled-release drug delivery systems. Drugs Pharm Sci 72:575–610
Jiang G-B, Quan D, Liao K, Wang H (2006) Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery. Mol Pharm 3:152–160
Jintapattanakit A, Junyaprasert VB, Mao S, Sitterberg J, Bakowsky U, Kissel T (2007) Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm 342:240–249
Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95:377–384
Kasaai MR (2007) Calculation of Mark–Houwink–Sakurada (MHS) equation viscometric constants for chitosan in any solvent–temperature system using experimental reported viscometric constants data. Carbohyd Polym 68:477–488
Kasoju N, Ali SS, Dubey VK, Bora U (2013) Exploiting the potential of Collagen as a natural biomaterial in drug delivery. J Proteins Proteomics 1
Kataoka K, Harada A, Nagasaki Y (2001) Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47:113–131
Kawaguchi T, Tsugane A, Higashide K, Endoh H, Hasegawa T, Kanno H, Seki T, Juni K, Fukushima S, Nakano M (1992) Control of drug release with a combination of prodrug and polymer matrix: Antitumor activity and release profiles of 2′, 3′-diacyl-5-fluoro-2′-deoxyuridine from poly (3-hydroxybutyrate) microspheres. J Pharm Sci 81:508–512
Kean T, Thanou M (2010) Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 62:3–11
Keshavarz T, Roy I (2010) Polyhydroxyalkanoates: bioplastics with a green agenda. Curr Opin Microbiol 13:321–326
Kessler B, Witholt B (2001) Factors involved in the regulatory network of polyhydroxyalkanoate metabolism. J Biotechnol 86:97–104
Kim GJ, Nie S (2005) Targeted cancer nanotherapy. Mater Today 8:28–33
Kim J, Conway A, Chauhan A (2008) Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. Biomaterials 29:2259–2269
Koch-Weser J, Sellers EM (1976) Binding of drugs to serum albumin. N Engl J Med 294:311–316
Kohmura E, Yuguchi T, Yoshimine T, Fujinaka T, Koseki N, Sano A, Kishino A, Nakayama C, Sakaki T, Nonaka M (1999) BDNF atelocollagen mini-pellet accelerates facial nerve regeneration. Brain Res 849:235–238
Kretlow JD, Klouda L, Mikos AG (2007) Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59:263–273
Kucharz EJ (1992) Degradation. In: The collagens: biochemistry and pathophysiology. Springer
Kumar JA, Pullakandam N, Prabu SL, Gopal V (2010) Transdermal drug delivery system: an overview. Int J Pharm Sci Rev Res 3:49–54
Kumar KS, Bhowmik D, Srivastava S, Paswan S, Dutta AS (2012) Sustained release drug delivery system potential. Pharma Innov 1
Kurkuri MD, Nussio MR, Deslandes A, Voelcker NH (2008) Thermosensitive copolymer coatings with enhanced wettability switching. Langmuir 24:4238–4244
Kutmalge M, Jadhav A, Ratnaparkhi M, Chaudhari S (2014) Sustained release drug delivery system. Terminology 1:2
Lachman L, Lieberman HA, Kanig JL (1986) The theory and practice of industrial pharmacy. Lea & Febiger
Lamarque G, Lucas J-M, Viton C, Domard A (2005) Physicochemical behavior of homogeneous series of acetylated chitosans in aqueous solution: role of various structural parameters. Biomacromol 6:131–142
Le Tien C, Lacroix M, Ispas-Szabo P, Mateescu M-A (2003) N-acylated chitosan: hydrophobic matrices for controlled drug release. J Controlled Release 93:1–13
Lee JS, Bae JW, Joung YK, Lee SJ, Han DK, Park KD (2008) Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle. Int J Pharm 346:57–63
Lee SY (1996) Biotechnol Bioeng 49:1–14
Lenz RW, Marchessault RH (2005) Bacterial polyesters: biosynthesis, biodegradable plastics and biotechnology. Biomacromol 6:1–8
Li VH, Robinson J, Lee V, Hui H (1987) Controlled drug delivery: fundamentals and applications. Marcel Dekker, Inc., New York, pp 373–432
Lin Y-H, Chen C-T, Liang H-F, Kulkarni AR, Lee P-W, Chen C-H, Sung H-W (2007) Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology 18:105102
Liu L, Fishman ML, Kost J, Hicks KB (2003) Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 24:3333–3343
Longer MA, Ch’ng HS, Robinson JR (1985) Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. J Pharm Sci 74:406–411
Lu C, Mu B, Liu P (2011) Stimuli-responsive multilayer chitosan hollow microspheres via layer-by-layer assembly. Colloids Surf, B 83:254–259
Lu X-Y, Ciraolo E, Stefenia R, Chen G-Q, Zhang Y, Hirsch E (2011) Sustained release of PI3K inhibitor from PHA nanoparticles and in vitro growth inhibition of cancer cell lines. Appl Microbiol Biotechnol 89:1423–1433
Lucas PA, Syftestad GT, Goldberg VM, Caplan AI (1989) Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a collagenous delivery vehicle. J Biomed Mater Res, Part A 23:23–39
Madison LL, Huisman GW (1999) Metabolic engineering of poly (3-hydroxyalkanoates): from DNA to plastic. Microbiol Mol Biol Rev 63:21–53
Maeda M, Tani S, Sano A, Fujioka K (1999) Microstructure and release characteristics of the minipellet, a collagen-based drug delivery system for controlled release of protein drugs. J Controlled Release 62:313–324
Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3:1377–1397
Mano JF (2008) Stimuli-responsive polymeric systems for biomedical applications. Adv Eng Mater 10:515–527
Mao S, Germershaus O, Fischer D, Linn T, Schnepf R, Kissel T (2005) Uptake and transport of PEG-graft-trimethyl-chitosan copolymer–insulin nanocomplexes by epithelial cells. Pharm Res 22:2058–2068
Mao S, Shuai X, Unger F, Wittmar M, Xie X, Kissel T (2005) Synthesis, characterization and cytotoxicity of poly (ethylene glycol)-graft-trimethyl chitosan block copolymers. Biomaterials 26:6343–6356
Mao S, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62:12–27
Mark S, Torchilin VP (2011) Drug delivery systems. Access Science. McGraw-Hill Companies
Martin L, Wilson CG, Koosha F, Uchegbu IF (2003) Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm 55:35–45
Marty J (1978) Nanoparticles-a new colloidal drug delivery system. Pharm Acta Helv 53:17–23
Matsuoka J, Sakagami K, Shiozaki S, Uchida S, Fujiwara T, Gohchi A, Orita K (1988) Development of an interleukin-2 slow delivery system. ASAIO Trans 34:729–731
Mazeau K, Rinaudo M (2004) The prediction of the characteristics of some polysaccharides from molecular modeling. Comparison with effective behavior. Food Hydrocolloids 18:885–898
Mehta R (2004) Topical and transdermal drug delivery: what a pharmacist needs to know. Inet Continuing education, InetCE.com, 1–10
Miyata T, Rubin AL, Stenzel KH, Dunn MW (1979) Collagen drug delivery device. Google Patents
Mizrahy S, Peer D (2012) Polysaccharides as building blocks for nanotherapeutics. Chem Soc Rev 41:2623–2640
Morris GA, Castile J, Smith A, Adams GG, Harding SE (2009) The kinetics of chitosan depolymerisation at different temperatures. Polym Degrad Stab 94:1344–1348
Morris GA, Castile J, Smith A, Adams GG, Harding SE (2009) Macromolecular conformation of chitosan in dilute solution: a new global hydrodynamic approach. Carbohyd Polym 76:616–621
Morris GA, Kök SM, Harding SE, Adams GG (2010) Polysaccharide drug delivery systems based on pectin and chitosan. Biotechnol Genet Eng Rev 27:257–284
Mourya V, Inamdar NN (2008) Chitosan-modifications and applications: opportunities galore. React Funct Polym 68:1013–1051
Muller RH, Keck CM (2004) Challenges and solutions for the delivery of biotech drugs—a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113:151–170
Muzzarelli R, Muzzarelli C (2009) Chitin and chitosan hydrogels. In: Handbook of hydrocolloids, 2nd edn. Elsevier
Nair LS, Laurencin CT (2007) Biodegradable polymers as biomaterials. Prog Polym Sci 32:762–798
Nazemi K, Azadpour P, Moztarzadeh F, Urbanska A, Mozafari M (2015) Tissue-engineered chitosan/bioactive glass bone scaffolds integrated with PLGA nanoparticles: a therapeutic design for on-demand drug delivery. Mater Lett 138:16–20
Nguyen DN, Raghavan SS, Tashima LM, Lin EC, Fredette SJ, Langer RS, Wang C (2008) Enhancement of poly (orthoester) microspheres for DNA vaccine delivery by blending with poly (ethylenimine). Biomaterials 29:2783–2793
Nguyen TTB, Hein S, Ng CH, Stevens WF (2008) Molecular stability of chitosan in acid solutions stored at various conditions. J Appl Polym Sci 107:2588–2593
Nimni ME, Cheung D, Strates B, Kodama M, Sheikh K (1987) Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res, Part A 21:741–771
Nitta SK, Numata K (2013) Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci 14:1629–1654
Nobes G, Maysinger D, Marchessault R (1998) Polyhydroxyalkanoates: materials for delivery systems. Drug Delivery 5:167–177
Nolkrantz K, Farre C, Brederlau A, Karlsson RI, Brennan C, Eriksson PS, Weber SG, Sandberg M, Orwar O (2001) Electroporation of single cells and tissues with an electrolyte-filled capillary. Anal Chem 73:4469–4477
Ogawa K, Yui T (1994) Effect of explosion on the crystalline polymorphism of chitin and chitosan. Biosci Biotechnol Biochem 58:968–969
Orts WJ, Nobes GA, Kawada J, Nguyen S, Yu G-E, Ravenelle F (2008) Poly (hydroxyalkanoates): biorefinery polymers with a whole range of applications. The work of Robert H. Marchessault. Can J Chem 86:628–640
Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–347
Papi M, Palmieri V, Maulucci G, Arcovito G, Greco E, Quintiliani G, Fraziano M, De Spirito M (2011) Controlled self assembly of collagen nanoparticle. J Nanopart Res 13:6141–6147
Parenteau-Bareil R, Gauvin R, Berthod F (2010) Collagen-based biomaterials for tissue engineering applications. Materials 3:1863–1887
Park JH, Saravanakumar G, Kim K, Kwon IC (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 62:28–41
Park SY, Lee BI, Jung ST, Park HJ (2001) Biopolymer composite films based on κ-carrageenan and chitosan. Mater Res Bull 36:511–519
Patnaik AN, Nagarjuna T, Thulasiramaraju T (2013) Sustained release drug delivery system: a modern formulation approach. Int J Res Pharm Nano Sci 2:586–601
Piez K (1985) Collagen. Encycl Polymer Sci 3:699–727
Piez KA (1984) Molecular and aggregate structures of the collagens. Elsevier, New York
Poirier Y, Nawrath C, Somerville C (1995) Production of polyhydroxyalkanoates, a family of biodegradable plastics and elastomers, in bacteria and plants. Nat Biotechnol 13:142
Popli H, Sharma S (1989) Trends in oral sustained release formulation-I. Eastern Pharm 32:99–103
Pourjavadi A, Barzegar S (2009) Smart pectin-based superabsorbent hydrogel as a matrix for ibuprofen as an oral non-steroidal anti-inflammatory drug delivery. Starch-Stärke 61:173–187
Prabaharan M, Mano J (2004) Chitosan-based particles as controlled drug delivery systems. Drug Delivery 12:41–57
Prabaharan M, Mano JF (2005) Hydroxypropyl chitosan bearing β-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug. Macromol Biosci 5:965–973
Prabaharan M, Reis R, Mano J (2007) Carboxymethyl chitosan-graft-phosphatidylethanolamine: amphiphilic matrices for controlled drug delivery. React Funct Polym 67:43–52
Prego C, Fabre M, Torres D, Alonso M (2006) Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 23:549–556
Rajam M, Pulavendran S, Rose C, Mandal A (2011) Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications. Int J Pharm 410:145–152
Rani K, Paliwal S (2014) A review on targeted drug delivery: its entire focus on advanced therapeutics and diagnostics. Sch J App Med Sci 2:328–331
Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (2013) Introduction-biomaterials science. In: Biomaterials science: an introduction to materials, 3rd edn. Elsevier Inc
Reddy C, Ghai R, Kalia VC (2003) Polyhydroxyalkanoates: an overview. Biores Technol 87:137–146
Rinaudo M (2006) Chitin and chitosan: properties and applications. Prog Polym Sci 31:603–632
Roldo M, Hornof M, Caliceti P, Bernkop-Schnürch A (2004) Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur J Pharm Biopharm 57:115–121
Rössler B, Kreuter J, Ross G (1994) Effect of collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro. Pharmazie 49:175–179
Rössler B, Kreuter J, Scherer D (1995) Collagen microparticles: preparation and properties. J Microencapsul 12:49–57
Roy K, Mao H-Q, Huang S-K, Leong KW (1999) Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 5:387
Sahithi B, Ansari S, Hameeda S, Sahithya G, Prasad DM, Lakshmi Y (2013) A review on collagen based drug delivery systems. Indian J Res Pharm Biotechnol 1:461
Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R (2007) Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. J Nanosci Nanotechnol 7:2833–2841
Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R (2007) Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromol 8:3054–3060
Sasisekharan V, Yathindra N (1999) The Madras Group and the structure of collagen. In: Proceedings of the Indian Academy of Sciences-Chemical Sciences. Springer, pp 5–12
Schatz C, Viton C, Delair T, Pichot C, Domard A (2003) Typical physicochemical behaviors of chitosan in aqueous solution. Biomacromol 4:641–648
Sendil D, Gürsel I, Wise DL, Hasrc V (1999) Antibiotic release from biodegradable PHBV microparticles. J Controlled Release 59:207–217
Seyednejad H, Gawlitta D, Dhert WJ, Van Nostrum CF, Vermonden T, Hennink WE (2011) Preparation and characterization of a three-dimensional printed scaffold based on a functionalized polyester for bone tissue engineering applications. Acta Biomater 7:1999–2006
Shah M, Ullah N, Choi MH, Kim MO, Yoon SC (2012) Amorphous amphiphilic P (3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation. Eur J Pharm Biopharm 80:518–527
Shah NM, Pool MD, Metters AT (2006) Influence of network structure on the degradation of photo-cross-linked PLA-b-PEG-b-PLA hydrogels. Biomacromol 7:3171–3177
Shantha Kumar T, Soppimath K, Nachaegari S (2006) Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotechnol 7:261–276
Sharma K, Singh V, Arora A (2011) Natural biodegradable polymers as matrices in transdermal drug delivery. Int J Drug Dev Res 3
Sharma R (2014) An overview of future prospect of Aloe vera gel as nano drug carrier. In: Shukla JP (ed) Technologies for sustainable rural development having potential of socioeconomic upliftment. Allied Publishers, New Delhi, 173–179
Shishatskaya E, Goreva A, Voinova O, Inzhevatkin E, Khlebopros R, Volova T (2008) Evaluation of antitumor activity of rubomycin deposited in absorbable polymeric microparticles. Bull Exp Biol Med 145:358–361
Shrivastav A, Kim H-Y, Kim Y-R (2013) Advances in the applications of polyhydroxyalkanoate nanoparticles for novel drug delivery system. BioMed Res Int 2013
Singh R, Lillard JW Jr (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–223
Singh S, Pandey VK, Tewari RP, Agarwal V (2011) Nanoparticle based drug delivery system: advantages and applications. Indian J Sci Technol 4:177–180
Singla A, Chawla M (2001) Chitosan: some pharmaceutical and biological aspects—an update. J Pharm Pharmacol 53:1047–1067
Sinha V, Singla A, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S (2004) Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1–33
Skaugrud Ø, Hagen A, Borgersen B, Dornish M (1999) Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnol Genet Eng Rev 16:23–40
Sriamornsak P (2003) Chemistry of pectin and its pharmaceutical uses: a review. Silpakorn Univ Int J 3:206–228
Srivastava A, Yadav T, Sharma S, Nayak A, Kumari AA, Mishra N (2015) Polymers in drug delivery. J Biosci Med 4:69
Steinbüchel A, Füchtenbusch B (1998) Bacterial and other biological systems for polyester production. Trends Biotechnol 16:419–427
Steinbüchel A, Schlegel H (1991) Physiology and molecular genetics of poly (β-hydroxyalkanoic acid) synthesis in Alcaligenes eutrophus. Mol Microbiol 5:535–542
Steinbüchel A, Valentin HE (1995) Diversity of bacterial polyhydroxyalkanoic acids. FEMS Microbiol Lett 128:219–228
Tahrir F, Ganji F, Ahooyi TM (2015) Injectable thermosensitive chitosan/glycerophosphate-based hydrogels for tissue engineering and drug delivery applications: a review. Recent Pat Drug Delivery Formulation 9:107–120
Takenaka H (1986) New formulation of bioactive materials. Pharm Technol Jpn 2:1083–1091
Tamilvanan S, Venkateshan N, Ludwig A (2008) The potential of lipid-and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Controlled Release 128:2–22
Tang Y, Singh J (2008) Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems. Int J Pharm 357:119–125
Terbojevich M, Cosani A, Conio G, Marsano E, Bianchi E (1991) Chitosan: chain rigidity and mesophase formation. Carbohyd Res 209:251–260
Timpl R (1984) Immunology of the collagens. In: Extracellular matrix biochemistry, pp 159–190
Torchilin V (2009) Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm 71:431–444
Torchilin VP (2007) Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9:E128–E147
Torchilin VP (2012) Multifunctional nanocarriers. Adv Drug Deliv Rev 64:302–315
Türesin F, Gürsel I, Hasirci V (2001) Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J Biomater Sci Polym Ed 12:195–207
Vårum KM, Anthonsen MW, Grasdalen H, Smidsrod O (1991) 13C-Nmr studies of the acetylation sequences in partially N-deacetylated chitins (chitosans). Carbohyd Res 217:19–27
Vårum KM, Antohonsen MW, Grasdalen H, Smidsrod O (1991) Determination of the degree of N-acetylation and the distribution of N-acetyl groups in partially N-deacetylated chitins (chitosans) by high-field nmr spectroscopy. Carbohyd Res 211:17–23
Vauthier C, Bouchemal K (2009) Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 26:1025–1058
Velásquez CL, Albornoz JS, Barrios EM (2008) Viscosimetric studies of chitosan nitrate and chitosan chlorhydrate in acid free NaCl aqueous solution. e-Polymers 8
Verma P, Thakur A, Deshmukh K, Jha A, Verma S (2010) Routes of drug administration. Int J Pharm Stud Res 1:54–59
Vikas K, Arvind S, Ashish S, Gourav J, Vipasha D (2011) Recent advances in Ndds (Nov el Drug Delivery System) for delivery of anti-hypertensive drugs. Int J Drug Dev Res 3
Vold IMN (2004) Periodate oxidised chitosans: structure and solution properties
Vroman I, Tighzert L (2009) Biodegradable polymers. Materials 2:307–344
Vuignier K, Schappler J, Veuthey J-L, Carrupt P-A, Martel S (2010) Drug–protein binding: a critical review of analytical tools. Anal Bioanal Chem 398:53–66
Vyas SP, Khar RK (2004) Targeted & controlled drug delivery: novel carrier systems. CBS Publishers & Distributors
Wani MS (2008) Controlled release system—a review. Pharm Rev 6:41–46
Watanabe M, Kawano K, Toma K, Hattori Y, Maitani Y (2008) In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. J Controlled Release 127:231–238
Wijekoon A, Fountas-Davis N, Leipzig ND (2013) Fluorinated methacrylamide chitosan hydrogel systems as adaptable oxygen carriers for wound healing. Acta Biomater 9:5653–5664
Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N (2010) Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater 9:923
Wu J, Su Z-G, Ma G-H (2006) A thermo-and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate. Int J Pharm 315:1–11
Wu J, Wei W, Wang L-Y, Su Z-G, Ma G-H (2007) A thermosensitive hydrogel based on quaternized chitosan and poly (ethylene glycol) for nasal drug delivery system. Biomaterials 28:2220–2232
Yadav N, Morris G, Harding S, Ang S, Adams G (2009) Various non-injectable delivery systems for the treatment of diabetes mellitus. Endocr Metab Immune Disord-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 9:1–13
Yagmurlu MF, Korkusuz F, Gürsel I, Korkusuz P, Örs Ü, Hasirci V (1999) Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: In vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J Biomed Mater Res, Part A 46:494–503
Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ (1999) Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Controlled Release 59:299–307
Yang YY, Wang Y, Powell R, Chan P (2006) Polymeric core-shell nanoparticles for therapeutics. Clin Exp Pharmacol Physiol 33:557–562
Yannas I, Burke J, Gordon P, Huang C, Rubenstein R (1980) Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res, Part A 14:107–132
Yannas I, Burke JF (1980) Design of an artificial skin. I. Basic design principles. J Biomed Mater Res, Part A 14:65–81
Yu D-G, Lin W-C, Yang M-C (2007) Surface modification of poly (L-lactic acid) membrane via layer-by-layer assembly of silver nanoparticle-embedded polyelectrolyte multilayer. Bioconjug Chem 18:1521–1529
Zhang X, Zhang H, Wu Z, Wang Z, Niu H, Li C (2008) Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur J Pharm Biopharm 68:526–534
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Fasiku, V.O. et al. (2019). Bionanopolymers for Drug Delivery. In: Gnanasekaran, D. (eds) Green Biopolymers and their Nanocomposites. Materials Horizons: From Nature to Nanomaterials. Springer, Singapore. https://doi.org/10.1007/978-981-13-8063-1_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-8063-1_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8062-4
Online ISBN: 978-981-13-8063-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)